Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism Mcl-1 inhibitors(Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitors), Apoptosis stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 1 | CN | 30 Jan 2022 | |
Bile Duct Neoplasms | Phase 1 | CN | 30 Jan 2022 | |
Liver Cancer | Phase 1 | CN | 30 Jan 2022 | |
Lung Cancer | Phase 1 | CN | 30 Jan 2022 | |
Myelodysplastic-Myeloproliferative Diseases | Phase 1 | CN | 30 Jan 2022 | |
Pancreatic Cancer | Phase 1 | CN | 30 Jan 2022 | |
Stomach Cancer | Phase 1 | CN | 30 Jan 2022 | |
Myelodysplastic Syndromes | Phase 1 | - | 01 Feb 2021 | |
Polycythemia Vera | Preclinical | US | - | |
Solid tumor | Preclinical | US | - |